These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28340974)

  • 21. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
    Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
    Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lower dementia risk in patients vaccinated against herpes zoster.
    Scherrer J; Salas J; Jacobs C; Wiemken T
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment.
    Patterson BJ; Myers K; Stewart A; Mange B; Hillson EM; Poulos C
    Expert Rev Vaccines; 2021 Jun; 20(6):729-741. PubMed ID: 33902368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
    Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of herpes zoster vaccination among Australian adults aged 65 and over.
    Ricks T; Trent MJ; MacIntyre CR
    Vaccine; 2022 Nov; 40(50):7182-7186. PubMed ID: 36336528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating Physician Attitudes and Practices Regarding Herpes Zoster Vaccination.
    Tsui E; Gillespie C; Perskin M; Zabar S; Wu M; Cohen EJ
    Cornea; 2018 Aug; 37(8):947-951. PubMed ID: 29578865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis.
    Wang Q; Yang L; Li L; Liu C; Jin H; Lin L
    JMIR Public Health Surveill; 2023 Mar; 9():e43893. PubMed ID: 36892937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Association Between Herpes Zoster Vaccination and Stroke Reduction Among Elderly Individuals.
    Klaric JS; Beltran TA; McClenathan BM
    Mil Med; 2019 Mar; 184(Suppl 1):126-132. PubMed ID: 30901393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications.
    Khan N; Shah Y; Trivedi C; Lewis JD
    Aliment Pharmacol Ther; 2017 Oct; 46(7):668-672. PubMed ID: 28805309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults.
    Chlibek R; Pauksens K; Rombo L; van Rijckevorsel G; Richardus JH; Plassmann G; Schwarz TF; Catteau G; Lal H; Heineman TC
    Vaccine; 2016 Feb; 34(6):863-8. PubMed ID: 26432913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium.
    Bilcke J; Marais C; Ogunjimi B; Willem L; Hens N; Beutels P
    Vaccine; 2012 Jan; 30(3):675-84. PubMed ID: 22120193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost Effectiveness of a Shingles Vaccine Booster for Currently Vaccinated Adults in the U.S.
    Le P; Rothberg MB
    Am J Prev Med; 2017 Dec; 53(6):829-836. PubMed ID: 29153126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herpes zoster vaccine coverage in Australia before and after introduction of a national vaccination program.
    Lin J; Wood JG; Bernardo C; Stocks NP; Liu B
    Vaccine; 2020 Apr; 38(20):3646-3652. PubMed ID: 32245643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of the Recombinant Zoster Vaccine in Adults Aged 50 and Older in the United States: A Claims-Based Cohort Study.
    Sun Y; Kim E; Kong CL; Arnold BF; Porco TC; Acharya NR
    Clin Infect Dis; 2021 Sep; 73(6):949-956. PubMed ID: 33580245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.
    de Boer PT; Pouwels KB; Cox JM; Hak E; Wilschut JC; Postma MJ
    Vaccine; 2013 Feb; 31(9):1276-83. PubMed ID: 23306360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza Vaccine Uptake in the Year After Concurrent vs Separate Influenza and Zoster Immunization.
    Rome BN; Feldman WB; Fischer MA; Desai RJ; Avorn J
    JAMA Netw Open; 2021 Nov; 4(11):e2135362. PubMed ID: 34797367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases.
    Yun H; Xie F; Baddley JW; Winthrop K; Saag KG; Curtis JR
    J Rheumatol; 2017 Jul; 44(7):1083-1087. PubMed ID: 28298565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes zoster vaccine awareness among people ≥ 50 years of age and its implications on immunization.
    Javed S; Javed F; Mays RM; Tyring SK
    Dermatol Online J; 2012 Aug; 18(8):2. PubMed ID: 22948052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing herpes zoster vaccination among older people in China: results from a discrete choice experiment.
    Zhang H; Zhang LR; Chu LC; Sun X; Jiang XW
    Public Health; 2023 Jul; 220():33-34. PubMed ID: 37263175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.